Search results for " costs" in Articles / App Notes
Article
Achieving Process Balance with Perfusion Bioreactors
With rising pressure to reduce costs and streamline bioprocess development, biopharmaceutical manufacturers are exploring the application of perfusion to a wider selection of biomolecules.
“Perfus…
Article
State of the Biopharmaceutical Industry: Lessons from 2018 Survey Data
5) Manufacturing costs are manageable. Survey data show that the lowest costs currently being attained with commercial scale recombinant protein/antibody manufacturing are now in the $100/gram range, …
Article
Biopharma Seeks Balance
With development and manufacturing playing such a crucial role, production challenges and high costs are recognized as roadblocks to the adoption of new therapies. Although costly, gene therapies can …
Article
Platform Technologies Improve Protein Expression
Manufacturers are seeking mechanisms for increasing efficiencies and reducing costs without compromising the safety and efficacy of their drug products. In addition to exploring novel production metho…
Article
Patenting Prospects for Cell-Based Therapies
It is also one that involves significant investment and, therefore, can be expected to have concomitantly significant costs to patients and their insurers. Accordingly, patent exclusivity will be impo…
Article
Downstream Processing for Cell-Based Therapies
The increased demand for hospital and social care, coupled with complex medical interventions, has led to spiralling costs for healthcare systems globally. Advanced therapies, including cell- and gene…
Article
Lessons Learned Accelerate Vaccine Development
Single-use systems, for example, contribute to reduced operating costs, simplification of facility design, and lead-time reduction. In addition, disposable technologies offer the potential to eliminat…
Article
A Bright Future for the Plasma Fractionation Industry
Perreault stressed that even with the ever-growing cost pressure on healthcare and treatment costs, one needs to be balanced when looking at how to handle that cost pressure, even if “biopharma is an …
Article
Biomanufacturing Outsourcing Globalization Continues
This strategy enables them to save on up-front facility costs while still evaluating processes to the point where they can tech-transfer a process to a CMO.
Recent years have seen more enthusiasm …
Article
Fermentation for the Future
Reinisch also notes that media costs for microbial fermentation are lower, although media costs for cell culture have been declining. Drivers of new technology development in microbial fermentation ar…